Lupus and allergies arise from different arms of the immune system, yet they share more biology than most people realize. Population studies show that people with lupus develop allergic conditions at significantly higher rates, drug reactions are strikingly common in lupus patients, and the same immune cells and antibodies involved in hay fever and hives also appear to fuel lupus flares and organ damage. The overlap runs deep enough that researchers are now testing allergy drugs as lupus treatments and exploring allergy-related antibodies as tools for predicting kidney complications.
How Often the Two Conditions Overlap
A large epidemiological study comparing lupus patients with matched controls found that atopic dermatitis was roughly twice as common in people with lupus (about 7% versus 3%), and asthma rates were also higher (about 11% versus 8%). The same study found that overall lupus risk climbed as the number of allergic conditions a person carried increased, rising from about 1.5-fold with one atopic disease to roughly 2.3-fold with multiple atopic diseases.1PubMed Central. Atopic Diseases and Systemic Lupus Erythematosus: An Epidemiological Study of the Risks and Correlations The pattern holds in younger populations as well. In a study of 118 children with lupus, about 14% had at least one confirmed allergic disease, with allergic rhinitis being the most common, followed by asthma and atopic dermatitis.2PubMed Central. Coexistence of Allergic Diseases in Pediatric Systemic Lupus Erythematosus Patients: Prevalence, Clinical manifestation and Severity
These numbers do not prove that one condition causes the other. They do suggest the two share either common triggers, common biology, or both. The next question is what that shared biology actually looks like under the hood.
The Immune Players They Have in Common
Lupus has traditionally been classified as an autoimmune disease driven primarily by one branch of immune signaling, while allergies are driven by another. But research over the past two decades has blurred that line. A growing body of evidence shows that the immune pathway most associated with allergies, the Th2 pathway, plays a meaningful role in lupus as well. The molecules underlying this pathway are now being explored as both diagnostic markers and treatment targets for lupus.3Autoimmunity Reviews. Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus
Three cell types illustrate the overlap especially well. Basophils, the white blood cells that release histamine during an allergic reaction, appear to contribute to lupus by amplifying the production of autoantibodies in an IgE-dependent manner. Research in both mouse models and human patients has shown that basophils are recruited to secondary lymphoid organs during active lupus, where they help drive the autoantibody response that damages tissues.4PubMed Central. The deleterious role of basophils in systemic lupus erythematosus Mast cells, the other major allergy cell, tell a similar story. Lupus patients have significantly higher blood levels of the receptor fragment that mast cells shed when they are activated, compared with healthy controls. The interpretation is that mast cells are being chronically triggered in lupus, contributing to the ongoing tissue damage that characterizes the disease.5PubMed Central. Expression and existence forms of mast cell activating molecules and their antibodies in systemic lupus erythematosus
Then there are anti-IgE autoantibodies. A significant number of lupus patients carry antibodies that target IgE itself, and the IgG fraction of those antibodies can trigger histamine release from basophils and skin mast cells. The same histamine cascades that give you hives after a bee sting may contribute to the vascular and joint inflammation characteristic of lupus.6PubMed. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity.
Shared Genetic Risk
The clinical overlap between lupus and allergic diseases has a genetic basis. A large genome-wide study integrating data from two major biobanks, covering over 100,000 cases and 400,000 controls, found that autoimmune and allergic diseases share positive genetic correlations beyond what their traditional classifications would predict. The analysis identified four genetic loci shared between six autoimmune and allergic diseases, and associations at two of those loci were confirmed in lupus specifically.7Annals of the Rheumatic Diseases. Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component
A separate analysis of 290 genetic loci previously linked to 16 autoimmune diseases found a statistically significant enrichment of loci that were also associated with allergy. Among those shared loci, about half had the same direction of effect for both allergies and autoimmune diseases, meaning the same genetic variant that raises your risk for one also raises your risk for the other. Shared genetic variants clustered in immune pathways and in regions of DNA that are active in immune cells.8PubMed. Shared genetic variants suggest common pathways in allergy and autoimmune diseases The takeaway is that susceptibility to lupus and susceptibility to allergies are not fully independent traits. They share portions of the same genetic architecture.
Why Drug Allergies Are So Common in Lupus
One of the most practically relevant connections between lupus and allergies involves medications. People with lupus report drug allergies at rates well above what you would see in the general population or in other autoimmune conditions. In one study, about a third of lupus patients reported drug allergies, compared with 18% of patients with rheumatoid arthritis, and sulfa drug allergy was especially overrepresented in the lupus group.9PubMed. Drug allergies may be more frequent in systemic lupus erythematosus than in rheumatoid arthritis A cohort of 417 lupus patients found that over 27% reported sulfa allergy specifically.10PubMed. Sulpha allergy in lupus patients: a clinical perspective
The problem is not limited to sulfa drugs. A case-control study found that lupus patients were significantly more likely than controls to report allergy to penicillins, cephalosporins, sulfonamides, and erythromycin. Sulfonamide allergy in particular was associated with lupus flares, meaning the allergic reaction itself could trigger a worsening of the underlying disease.11Journal of Rheumatology. Antibiotic allergy in systemic lupus erythematosus: A case-control study This creates a frustrating clinical problem. Lupus patients are immunosuppressed and prone to infections, so they need antibiotics more often. But they are also more likely to react badly to those antibiotics, and the reaction can make the lupus itself worse.
There is a separate but related phenomenon worth noting: certain drugs can actually induce a lupus-like syndrome. Drug-induced lupus involves a handful of medications with specific pharmacological properties, but some other drugs appear to trigger lupus through allergic reactions that in turn activate or mimic the disease.12Mayo Clinic Proceedings. Drug-Induced Systemic Lupus Erythematosus This distinction matters for treatment decisions. Drug-induced lupus usually resolves when the offending medication is stopped, while a drug allergy that triggers a flare of preexisting lupus may need both the allergy and the flare managed simultaneously.
When a Flare Looks Like an Allergic Reaction
A less appreciated difficulty is telling the two apart clinically. Rashes, fever, joint pain, and mucosal inflammation can all show up in both a lupus flare and a genuine allergic reaction. The usual blood tests for lupus activity, including complement levels and anti-dsDNA antibodies, are not always reliable at distinguishing between the two. Inflammatory markers like C-reactive protein can rise in both scenarios, though a markedly elevated CRP is somewhat more suggestive of infection or allergy than of lupus alone. No single laboratory test definitively separates an allergic reaction from a flare; diagnosis ends up relying on a combination of clinical judgment, blood work, and sometimes tissue biopsy.13PubMed Central. Allergic reactions in systemic lupus erythematosus: From pathogenic pathways to clinical practice
This is a real-world headache for lupus patients. If you have lupus and suddenly develop a new rash while on a medication, your doctor has to figure out whether the medication caused an allergic reaction, whether your lupus is flaring for other reasons, or whether both are happening at once. The immunosuppressive drugs that lupus patients take can also muddy the picture by altering how the body mounts an allergic response. Getting the diagnosis right matters because the treatments point in different directions: an allergic reaction might call for stopping a drug and giving antihistamines, while a lupus flare might call for intensifying immunosuppression.
IgE Antibodies as a Biomarker for Kidney Damage
One of the more surprising findings in this space is that IgE antibodies directed against the body’s own DNA appear to track with kidney inflammation in lupus. Lupus nephritis, where the immune system attacks the kidneys, is one of the most serious complications of the disease. Researchers found that levels of anti-dsDNA IgE autoantibodies were strongly correlated with interstitial inflammation in the kidneys, and patients who carried these antibodies were more likely to develop acute kidney injury.14PubMed Central. Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation
This has led to work on whether the allergy-associated antibody class could serve as a practical clinical test. A study examining patients with lupus nephritis who were in remission found that those with anti-dsDNA IgE levels above a certain threshold had significantly worse relapse-free survival. The test had a positive predictive value of 0.8 for severe lupus nephritis relapse, meaning that when it flagged someone as high-risk, it was right about 80% of the time. Interestingly, the conventional biomarker, anti-dsDNA IgG, was not associated with subsequent relapse in this study.15RMD Open. Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse If confirmed in larger studies, this would mean that an antibody class everyone associates with hay fever and peanut allergies could become a better predictor of lupus kidney relapse than the standard tests rheumatologists currently use.
Testing Allergy Drugs as Lupus Treatments
The biological overlap between lupus and allergy has naturally raised the question of whether allergy treatments could help lupus patients. The most direct test of this idea involved omalizumab, a monoclonal antibody that blocks IgE and is widely used for severe asthma and chronic hives. A small randomized trial called STOP LUPUS found that lupus disease activity scores improved in the omalizumab group at 16 weeks compared with placebo. The scores also improved in a group that initially received placebo and then switched to omalizumab during an open-label phase. However, the researchers cautioned that the average improvement was modest (about a 2-point reduction on the disease activity scale), and it may not be clinically meaningful.16PubMed Central. Safety and Tolerability of Omalizumab, A Randomized Clinical Trial of Humanized anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus (STOP LUPUS) There was also a trend toward worsening scores once the drug was stopped, which at least suggests the effect was real even if small.
The traffic goes in both directions. Hydroxychloroquine, a mainstay lupus drug, has been tested for chronic urticaria (persistent hives). In a trial of patients with chronic autoimmune urticaria, those treated with hydroxychloroquine showed improvements in quality of life and symptom severity, though the effects on objective urticaria scores just missed statistical significance.17PubMed. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation Neither of these examples represents a breakthrough, but they illustrate the point: drugs developed for one side of this overlap sometimes show activity on the other side, which makes sense given the shared immune machinery.
Children with Eczema and Later Lupus Risk
The connection between allergies and lupus may be particularly important in children. A study following over 190,000 children newly diagnosed with atopic dermatitis, compared with matched controls, found that the incidence of juvenile-onset lupus was roughly 2.9-fold higher in children with eczema. The risk was greatest in the first five years after the eczema diagnosis, when it climbed to about four-fold. Girls and older children with eczema faced the highest risk.18PubMed. Increased Incidence of juvenile onset systemic lupus erythematosus in children with atopic dermatitis
This does not mean that eczema causes lupus. It may simply mean that children whose immune systems are prone to one kind of immune dysregulation are also prone to another. But the finding has practical implications for pediatricians monitoring children with persistent or severe atopic dermatitis, especially if other risk factors for lupus are present. Unexplained joint pain, mouth sores, or rashes in unusual patterns in a child with a history of eczema might warrant closer attention.
Environmental Triggers and the Barrier Hypothesis
Beyond genetics and shared cell types, the environment may help explain why lupus and allergies so often travel together. The epithelial barrier theory proposes that modern environmental exposures, including detergents, microplastics, and pollutants, damage the lining of the skin, gut, and airways. When that barrier breaks down, bacteria from the body’s surface can migrate into deeper tissues along with allergens and toxins. The resulting chronic inflammation around the epithelium, along with a loss of microbial diversity, could set the stage for both allergic and autoimmune responses.19PubMed Central. The epithelial barrier theory: Development and exacerbation of allergic and other chronic inflammatory diseases
A related idea, the hygiene hypothesis, holds that the modern decline in exposure to parasites and diverse microbes has left the immune system without the regulatory signals it evolved to expect. This “derangement of immunoregulatory mechanisms” has been linked to rising rates of both allergic and autoimmune conditions in industrialized countries.20PubMed. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms Neither theory fully explains the lupus-allergy link on its own, but both offer plausible environmental mechanisms that could amplify whatever genetic predisposition a person carries.
Hormones and the Gender Gap
Lupus is famously more common in women, with a female-to-male ratio of roughly nine to one during the reproductive years. Allergic diseases also show sex-based differences in prevalence, though the gap is narrower. Estrogen appears to be one connecting thread. Research in animal models has shown that estrogen tends to push the immune system toward the kind of response associated with both allergy and lupus, while suppressing the type of immune activity involved in other autoimmune conditions. Estrogen activates immune cells through multiple signaling pathways, and in lupus-prone mice, it drives the same type of immune shift that characterizes allergic inflammation.21Clinical Immunology. Estrogen as an immunomodulator This hormonal push may partly explain why women with lupus are disproportionately likely to also have allergic conditions, and why lupus often flares during periods of hormonal change.
Diet and Symptom Patterns
Many lupus patients report that certain foods seem to worsen their symptoms, and the pattern sometimes resembles food hypersensitivity more than classic autoimmune flaring. A survey-based study of lupus patients who made plant-based dietary changes found that symptom severity ratings dropped by about 21% overall after the changes. The largest improvements came from reducing dairy, cutting processed foods, and adopting vegan eating patterns, each associated with roughly a quarter reduction in symptom severity. Fatigue, joint and muscle pain, and mood were among the symptoms patients most often reported improving.22PubMed Central. Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus This was self-reported data, not a controlled trial, so the results carry the usual caveats about placebo effects and recall bias. Still, the pattern is consistent with the idea that gut barrier integrity and immune reactivity to food components play a role in lupus symptom burden, tying back to the broader theme of epithelial barrier function and immune regulation that connects both conditions.